ERA

Download the full-sized PDF of Adenoviral Vectors Targeted to Hepatocellular CarcinomaDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3QN5ZJ4H

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Adenoviral Vectors Targeted to Hepatocellular Carcinoma Open Access

Descriptions

Other title
Subject/Keyword
E1b-55K
Oncolytic virus
Adenovirus
Hepatocellular Carcinoma
VA-RNA
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Sharon, David
Supervisor and department
Hitt, Mary M (Oncology)
Examining committee member and department
Shaw, Andrew (Oncology)
Mymryk, Joe (University of Western Ontario, Oncology)
Smiley, James (Medical Microbiology and Immunology)
Fu, YangXin (Oncology)
Department
Department of Oncology
Specialization
Experimental Oncology
Date accepted
2013-09-29T16:53:22Z
Graduation date
2013-11
Degree
Doctor of Philosophy
Degree level
Doctoral
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer and third leading cause of cancer-related deaths. Due to the low response to current HCC therapy, many studies have been done to identify novel HCC therapeutics. Non-replicating first generation adenovirus (Ad) vectors and conditionally replicating oncolytic Ads have been extensively studied as potential HCC therapies. Several mechanisms have been utilized to target these Ads to HCC cells in order to reduce the potentially high liver toxicity associated with this therapeutic approach. Since the liver-specific miR-122 is downregulated in many HCC cells, the use of RNA interference-mediated post-transcriptional targeting of therapeutic genes by insertion of miR-122 targeted sequences is a promising targeting modality for Ads. Although miR-122-mediated targeting of FGAd vectors encoding pro-apoptotic genes may have potential as therapies for HCC, amplification of these vectors is currently challenging due to the induction of premature apoptosis of the packaging cells. In this study, we have attempted to circumvent this difficulty through post-transcriptional silencing of the apoptotic gene in packaging cells expressing miR-122. We have also utilized miR-122-mediated targeting modality to increase the specificity of oncolytic Ads for HCC cells. Furthermore, we show that HCC selectivity was increased by deletion E1b and VA-RNA genes. While these deletions reduced the activity of the virus, we found that the oncolytic activity of the virus could be enhanced by treatment with 2-aminopurine. Since VA-RNA-deleted Ads are attenuated in HEK293 cells commonly used for packaging virus, we have identified the HCC cell line Hep3B as a potential alternative for the amplification of these Ads. In our studies presented here, we have examined systems to increase the concentrations of first-generation and oncolytic Ads that are challenging to amplify. Furthermore, we show that Ads lacking E1b and VA-RNA genes have high potential as a novel targeted HCC therapy.
Language
English
DOI
doi:10.7939/R3QN5ZJ4H
Rights
Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission.
Citation for previous publication
Sharon D, Schümann M, MacLeod S, McPherson R, Chaurasiya S, et al. (2013) 2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells. PLoS ONE 8(6): e65222.

File Details

Date Uploaded
Date Modified
2015-01-08T08:05:24.731+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 10902971
Last modified: 2015:10:12 19:11:05-06:00
Filename: Sharon_David_Fall 2013.pdf
Original checksum: 3e97253c0023cf7e0a8e06a74a51007e
Well formed: true
Valid: false
Status message: Invalid page tree node offset=112020
Status message: Invalid outline dictionary item offset=10831776
Activity of users you follow
User Activity Date